Fernando López‐Ríos
About
Fernando López‐Ríos is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research.
According to data from OpenAlex, Fernando López‐Ríos has authored 177 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 85 papers in Pulmonary and Respiratory Medicine and 54 papers in Cancer Research. Recurrent topics in Fernando López‐Ríos's work include Lung Cancer Treatments and Mutations (52 papers), Cancer Genomics and Diagnostics (45 papers) and Colorectal Cancer Treatments and Studies (17 papers). Fernando López‐Ríos is often cited by papers focused on Lung Cancer Treatments and Mutations (52 papers), Cancer Genomics and Diagnostics (45 papers) and Colorectal Cancer Treatments and Studies (17 papers). Fernando López‐Ríos collaborates with scholars based in Spain, United States and United Kingdom. Fernando López‐Ríos's co-authors include Esther Conde, Manuel Hidalgo, Keith M. Kerr, José Luis Rodríguez‐Peralto, Manfred Dietel, Montse Sánchez‐Céspedes, Ana Suárez‐Gauthier, Marc Ladanyi, Reinhard Büttner and Bárbara Angulo and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Fernando López‐Ríos
175 papers receiving 6.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fernando López‐Ríos Spain | 44 | 3.2k | 2.7k | 2.1k | 1.8k | 876 | 177 | 6.4k | ||
| Gustavo Baretton Germany | 46 | 3.0k 0.9× | 1.9k 0.7× | 2.5k 1.2× | 1.5k 0.8× | 916 1.0× | 312 | 7.3k | ||
| Christopher Poremba Germany | 54 | 2.5k 0.8× | 2.2k 0.8× | 3.0k 1.4× | 1.8k 1.0× | 1.3k 1.5× | 166 | 7.7k | ||
| Antonio Llombart‐Bosch Spain | 43 | 1.8k 0.6× | 3.4k 1.3× | 1.8k 0.9× | 1.0k 0.6× | 1.1k 1.3× | 294 | 6.7k | ||
| Martine Antoine France | 42 | 2.2k 0.7× | 2.4k 0.9× | 1.0k 0.5× | 957 0.5× | 1.2k 1.3× | 188 | 5.5k | ||
| S. Pilotti Italy | 54 | 4.0k 1.3× | 2.8k 1.0× | 3.1k 1.5× | 1.5k 0.8× | 1.5k 1.7× | 175 | 9.2k | ||
| Sanja Đačić United States | 51 | 4.1k 1.3× | 6.1k 2.2× | 2.3k 1.1× | 2.2k 1.2× | 869 1.0× | 171 | 9.5k | ||
| Gunhild Mechtersheimer Germany | 41 | 2.5k 0.8× | 2.4k 0.9× | 1.8k 0.9× | 896 0.5× | 1.4k 1.6× | 193 | 6.7k | ||
| Rohit Bhargava United States | 41 | 2.8k 0.9× | 1.2k 0.4× | 1.6k 0.8× | 2.4k 1.3× | 1.1k 1.3× | 171 | 5.5k | ||
| Emina Torlakovic Canada | 33 | 3.6k 1.1× | 2.0k 0.7× | 1.1k 0.5× | 1.1k 0.6× | 2.5k 2.8× | 139 | 5.9k | ||
| Rajmohan Murali United States | 51 | 4.3k 1.4× | 2.2k 0.8× | 3.1k 1.5× | 1.6k 0.9× | 560 0.6× | 179 | 8.5k |
Countries citing papers authored by Fernando López‐Ríos
Since
Specialization
Citations
This map shows the geographic impact of Fernando López‐Ríos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando López‐Ríos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando López‐Ríos more than expected).
Fields of papers citing papers by Fernando López‐Ríos
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Fernando López‐Ríos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando López‐Ríos. The network helps show where Fernando López‐Ríos may publish in the future.
Co-authorship network of co-authors of Fernando López‐Ríos
This figure shows the co-authorship network connecting the top 25 collaborators of Fernando López‐Ríos. A scholar is included among the top collaborators of Fernando López‐Ríos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando López‐Ríos. Fernando López‐Ríos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Alborelli, Ilaria, Melanie Demes, Peter J. Wild, et al.. (2025). ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay. SHILAP Revista de lepidopterología. 6(3). 19–19.
2.
Hofman, Paul, Petros Christopoulos, Nicky D’Haene, et al.. (2025). Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer. Lung Cancer. 201. 108107–108107.
3.
Repetto, Matteo, Marina Chiara Garassino, Herbert H. Loong, et al.. (2024). NTRK gene fusion testing and management in lung cancer. Cancer Treatment Reviews. 127. 102733–102733.
4.
Cabo, Horacio, Esther Conde, Susana Hernández, et al.. (2024). Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC. JTO Clinical and Research Reports. 6(3). 100778–100778.
5.
Carretero‐Barrio, Irene, Lara Pijuán, Fernando López‐Ríos, et al.. (2024). Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology. Scientific Reports. 14(1). 24163–24163.
6.
Hernández, Susana, Esther Conde, Marta Alonso de la Varga, et al.. (2023). A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma. Translational Lung Cancer Research. 12(7). 1549–1562.
7.
Arriola, Edurne, Reyes Bernabé, Rosario García Campelo, et al.. (2023). Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non–Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO Precision Oncology. 7(7). e2200546–e2200546.
8.
Kerr, Keith M., Lukas Bubendorf, Fernando López‐Ríos, et al.. (2023). Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists. Histopathology. 84(3). 429–439.
9.
Mielgo-Rubio, Xabier, M. Martín, Jordi Remón, et al.. (2021). Targeted Therapy Moves to Earlier Stages of Non-Small-Cell Lung Cancer: Emerging Evidence, Controversies and Future Challenges. Future Oncology. 17(30). 4011–4025.
10.
Quintanal-Villalonga, Àlvaro, Irene Ferrer, Elizabeth Guruceaga, et al.. (2020). FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy. EBioMedicine. 53. 102683–102683.
11.
Mielgo-Rubio, Xabier, Virginia Calvo, J. Luna, et al.. (2020). Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers. Cancers. 12(11). 3459–3459.
12.
Hidalgo, Manuel, Carlos Plaza, Mónica Musteanu, et al.. (2015). SPARC Expression Did Not Predict Efficacy of nab -Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial. Clinical Cancer Research. 21(21). 4811–4818.
13.
Garralda, Elena, Keren Paz, Pedro P. López‐Casas, et al.. (2014). Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment. Clinical Cancer Research. 20(9). 2476–2484.
14.
Castillo, Sandra D., Ander Matheu, Julián Carretero, et al.. (2011). Novel Transcriptional Targets of the SRY-HMG Box Transcription Factor SOX4 Link Its Expression to the Development of Small Cell Lung Cancer. Cancer Research. 72(1). 176–186.
15.
Thunnissen, Erik, Keith M. Kerr, Felix Herth, et al.. (2011). The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer. 76(1). 1–18.
16.
Messersmith, Wells A., N.V. Rajeshkumar, Aik Choon Tan, et al.. (2009). Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts. Molecular Cancer Therapeutics. 8(6). 1484–1493.
17.
Song, Dongweon, Raghothama Chaerkady, Aik Choon Tan, et al.. (2008). Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer. Molecular Cancer Therapeutics. 7(10). 3275–3284.
18.
López‐Ríos, Fernando, Shannon Chuai, Raja M. Flores, et al.. (2006). Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction. Cancer Research. 66(6). 2970–2979.
19.
Delgado, Juan F., Esther Conde, Violeta Sánchez, et al.. (2005). Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Chronic Heart Failure. European Journal of Heart Failure. 7(6). 1011–1016.
20.
López‐Ríos, Fernando, José Luis Rodríguez‐Peralto, Esther Castaño, & Amparo Benito. (1999). Squamous Cell Carcinoma Arising in a Cutaneous Epidermal Cyst. American Journal of Dermatopathology. 21(2). 174–177.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Gustavo Baretton Breakdown of academic impact, for papers by Christopher Poremba Breakdown of academic impact, for papers by Antonio Llombart‐Bosch Breakdown of academic impact, for papers by Martine Antoine Breakdown of academic impact, for papers by S. Pilotti Breakdown of academic impact, for papers by Sanja Đačić Breakdown of academic impact, for papers by Gunhild Mechtersheimer Breakdown of academic impact, for papers by Rohit Bhargava Breakdown of academic impact, for papers by Emina Torlakovic Breakdown of academic impact, for papers by Rajmohan Murali